Fibroblast activation protein α (FAPα) vaccine in combination with curcumin was shown to significantly inhibit TNFα-induced EMT in melanoma cells by targeting indolamine-2,3-dioxygenase, inhibit tumor growth and prolong the survival of mice implanted with melanoma cells [198]. The gene discussed is FAP; the disease is melanoma.